NCT05012319

Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19

A Double-Blinded, Placebo-Controlled Parallel, Phase 3 Clinical Efficacy Study Evaluating Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Salmaniya Medical Complex · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study Design: This is a double-blind, placebo-controlled, Phase 3 clinical efficacy study evaluating NONS in adult volunteers as a treatment for high-risk asymptomatic and symptomatic individuals with mild COVID-19 infection. thru facility).

Detailed description

Study Design: This is a double-blind, placebo-controlled, Phase 3 clinical efficacy study evaluating NONS in adult volunteers as a treatment for high-risk asymptomatic and symptomatic individuals with mild COVID-19 infection.

Conditions

• Covid19

Interventions

Type	Name	Description
DRUG	to be given as a treatment	Nitric Oxide Nasal Spray "Enovid"

Timeline

• Start date: 2021-08-05
• Primary completion: 2022-03-30
• Completion: 2022-03-30
• First posted: 2021-08-19
• Last updated: 2021-08-19

Locations

1 site across 1 country: Bahrain